Clinical Trial

Melatonin Effects on Cardiovascular Disease Mechanisms in Midlife Women: A Randomized Clinical Trial

Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this research is to study the effects of 12 weeks of melatonin supplementation compared to placebo in women who are in the menopause transition (perimenopause) and have high blood pressure.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-09 -> 2027-09 2026-08-14
minor Completion pushed: 2027-01 -> 2028-01 2026-08-14
Trial Details
NCT Number NCT06826755
Lead Sponsor Mayo Clinic
Conditions Perimenopause, Hypertension
Enrollment 70 participants
Start Date 2025-05-23
Primary Completion 2027-09 (estimated)
Study Completion 2028-01 (estimated)
Updated on ClinicalTrials.gov 2026-08-13